Sample Article - Disposing of Expired Drugs and Chemicals: New Options for Compounders

Sample Articles from IJPC

About IJPC

The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly scientific and professional journal emphasizing quality pharmaceutical compounding.

The Journal is available in both printed and electronic format with digital versions of individual articles and complete issues delivered in Adobe® Acrobat PDF format.

Search the Journal by issue, topic or keyword.

Request a free copy of the Journal

Request a copy of
"Disposing of Expired Drugs and Chemicals: New Options for Compounders"

Read Abstract

A link to this sample article download page may be freely posted on web sites, chat rooms, and message boards provided that attribution to IJPC is included. The URL for this item is http://ijpc.com/Sample/Article.cfm?SID=94

The sample document may NOT be electronically posted, published, or redistributed without the prior permission of IJPC.

Complete the following to have a download link emailed to you.

Name:
Email:
Organization:
Used For:

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2008 Pg. 38-47 View Sample	Disposing of Expired Drugs and Chemicals: New Options for Compounders Author(s): Vail Jane
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Jan/Feb 2008 Pg. 87	PostScription: Consumer Options for Disposal of Unused Medications Author(s): Vail Jane
Sep/Oct 2010 Pg. 366-369	Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response Author(s): Briggs Valerie
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 268	PreScription: Factors Related to Drug Waste and Pharmacy Solutions Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 210	Standard Operating Procedure: Disposal of Chemicals Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 19-20	Compounding Pharmacy: A Unique Service for a Unique Population Author(s): Williams LaVonn A, Franck Paul
Nov/Dec 2021 Pg. 446-462	Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021 Author(s): Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
May/Jun 2016 Pg. 202-206	Does Your Drug Expertise Include Clinical Pharmaceutics? Author(s): Newton David W
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 456-460	Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Author(s): Lyon Joanna
Jul/Aug 2022 Pg. 298-301	The Role of Compounding Pharmacists During Drug Shortages Author(s): Ofei Kelvin
Jul/Aug 2013 Pg. 339-343	Patient-centered Care as Value-added Service by Compounding Pharmacists Author(s): McPherson Timothy B, Fontane Patrick E, Day Jonathan R
Jan/Feb 2014 Pg. 87	PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services Author(s): Lees Deril J
Jul/Aug 2012 Pg. 294-298	Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Author(s): Allen Loyd V Jr, Williams LaVonn A
Mar/Apr 2011 Pg. 92	PreScription: Discontinued Drugs and Drug Shortages Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 358-362	Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Author(s): Cabaleiro Joe
Mar/Apr 2022 Pg. 100-109	Allowing Compounding Pharmacies to Address Drug Shortages Author(s): Broughel James
Mar/Apr 2004 Pg. 101-105	Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Jan/Feb 2008 Pg. 74-82	Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Author(s): Huffman DC, Holmes Erin R
May/Jun 2006 Pg. 175-183	The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Author(s): Stephenson Kenna, Jones William, Stephenson Douglas M M
Sep/Oct 2014 Pg. 379-380	Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Author(s): Blankenship Cynthia E
Sep/Oct 2015 Pg. 377-380	The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
Sep/Oct 2015 Pg. 383-386	Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Author(s): Donnelly Ronald F
Jan/Feb 2017 Pg. 47-56	Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Author(s): Akers Michael J
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 30-39	Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients Author(s): McElhiney Linda F
Mar/Apr 2018 Pg. 108-121	Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Jan/Feb 2005 Pg. 44-46	The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Author(s): Allen Loyd V Jr, Ashworth Lisa D
Jul/Aug 2002 Pg. 271-273	Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Author(s): Kramer Mark A, Grilley Bambi J
Jul/Aug 2012 Pg. 350-351	PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Author(s): Allen Loyd V Jr, Williams LaVonn A
Sep/Oct 2015 Pg. 389-390	Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 358-362	Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Author(s): Lopez C Vidal, Rios GL Quito
Jan/Feb 2009 Pg. 56-62	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2010 Pg. 131-133	Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs Author(s): Burke John, Hill Jeff
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 254-261	Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
Nov/Dec 2006 Pg. 446-448	Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 350-351	PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 104-106	Standing Together Fixing the Drug Quality and Security Act Author(s): Miller David G
Sep/Oct 2014 Pg. 358-364	Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Author(s): Palma Elisabetta, Bufarini Celestino
Sep/Oct 2021 Pg. 396-400	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 154-159	Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes Author(s): de Wilde Sofieke, Crul Mirjam, Breukels Oscar
Jan/Feb 2014 Pg. 20-29	Good Enough for America Author(s): Worthen Dennis B
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Sep/Oct 2017 Pg. 373-380	Documentation: Records and Reports Author(s): Akers Michael J
Jan/Feb 2020 Pg. 44-50	Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Author(s): Allen Loyd V Jr
Mar/Apr 2001 Pg. 140-144	Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing Author(s): Douglass Kate, Kastango Eric S
Mar/Apr 2004 Pg. 107-109	Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo. Author(s): Allen Loyd V Jr
Nov/Dec 1997 Pg. 377-378	Ambulatory Care Medicine: Definition and Scope of Service Author(s): Wenmark William H
Jan/Feb 2004 Pg. 36-39	Developing and Providing Compounding Services for Hospitals Involved in a Merger Author(s): McElhiney Linda F
Jul/Aug 2012 Pg. 268	PreScription: Drug Shortages and Discontinued Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 364-371	Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Author(s): Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
Nov/Dec 2022 Pg. 444	PreScription: Compounded Drugs Often Become Manufactured Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 394-395	Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients Author(s): Moore Renee
Jan/Feb 2014 Pg. 35-36	U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Author(s): Miller David G
Nov/Dec 2016 Pg. 457-458	U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Author(s):
May/Jun 2016 Pg. 217-222	Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Author(s): Akers Michael J
Jul/Aug 2020 Pg. 296-297	Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Author(s): Brunner Scott
Nov/Dec 2020 Pg. 501-508	Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Jan/Feb 2021 Pg. 52-61	Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Author(s): Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jul/Aug 2018 Pg. 345-349	Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Author(s): Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
May/Jun 2019 Pg. 182-186	How to Develop and Maintain a Hazardous Drug List Author(s): Dillon L Rad
May/Jun 2013 Pg. 180	PreScription: Compounding for Drug Shortages Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 302-307	Treating Inner Ear Disorders with Intratympanic Drug Administration Author(s): McElhiney Linda F
Sep/Oct 2009 Pg. 400-403	Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Author(s): Gilbert John A
May/Jun 2000 Pg. 180-181	Compounding OTC Drugs: A Legal Perspective Author(s): Gibbs Jeffrey N, Mazan Kate Duffy
May/Jun 2000 Pg. 188-189	Wish You Were Here: Oklahoma Frontier Drug Store Museum Author(s): Worthen Dennis B
Jul/Aug 2004 Pg. 292-293	Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product Author(s): Allen Loyd V Jr
Jul/Aug 2002 Pg. 311-315	Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Saenz Christopher
Mar/Apr 1997 Pg. 121-122	The Compatibility of Common Respiratory Therapy Drug Combinations Author(s): Owsley Heather D, Rusho William F
Jan/Feb 2003 Pg. 21-23	Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Author(s): Vail Jane
Jan/Feb 2003 Pg. 44-45	Determining the Availability of a Commercial Drug Author(s):
Sep/Oct 2007 Pg. 426-432	Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Author(s): Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
Sep/Oct 2007 Pg. 438-439	PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 201-205	Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Author(s): Harrington Catherine A, Cauffield Jacintha
Sep/Oct 2006 Pg. 377-379	Basics of Compounding for Hazardous Drugs, Part 1: An Introduction Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 22-23	The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Author(s): Brunner Scott
Jul/Aug 2023 Pg. 340-346	Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Nov/Dec 2023 Pg. 450-453	Drug Utilization Review: Our Patients Deserve Our Very Best Author(s): Jackson Kathleen
Sep/Oct 2022 Pg. 385-395	Compounding with Biotechnology Products, Part 1: General Considerations Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 149-151	Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 150-151	Drug Products and Drug Packaging for the Elderly Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 424-431	In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs Author(s): Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
Jan/Feb 2019 Pg. 35-44	Basics of Compounding: Standardization of Compounded Medications Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 454-461	How to Qualify Container Closure Systems for Intended Use, Part 1 Author(s): Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
Mar/Apr 2014 Pg. 94-99	A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Author(s): Marks Zach
Jul/Aug 2015 Pg. 280-287	Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Author(s): Allen Loyd V
Mar/Apr 2018 Pg. 95-107	Pharmacogenomics: Precision Pharmacy in 503A Compounding Author(s): Drummond Joseph, Bennet Daron, Allen Loyd V Jr
Mar/Apr 2022 Pg. 92	PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry" Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 32-33	U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Author(s): Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Jul/Aug 2007 Pg. 326-327	Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Author(s): Kupiec Tom, Kemp Jesse
May/Jun 2008 Pg. 276-278	Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2007 Pg. 282-286	Premarin: The Intriguing History of a Controversial Drug Author(s): Vance Dwight A
Jan/Feb 2007 Pg. 56-58	Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding Author(s): Anderson Derick
May/Jun 2006 Pg. 230-233	Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Author(s): Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2001 Pg. 97-100	Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Author(s): Chan Debora Schotik
Jul/Aug 2002 Pg. 267-270	Facilities and Procedures for Compounding Hazardous Drugs Author(s): Rahe Hank
Jan/Feb 2001 Pg. 69-73	Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Williams Kimberly Y, Baker Ma
Jan/Feb 2002 Pg. 11-12	The Problem of Drug Diversion Author(s): Burke John J
Jul/Aug 1999 Pg. 321-324	Rapid Pharmacokinetic Evaluation of Topical Drug Formulations Author(s): Garzouzi Victoria L, Reifenrath William G
Jul/Aug 2000 Pg. 261-263	Compounding Using Hazardous Drugs Author(s): Lau Kellie
Mar/Apr 2004 Pg. 123-125	An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs Author(s): Monnot Chris L
May/Jun 2005 Pg. 173	Book Reviews: Veterinary Drug Handbook: Client Information Edition Author(s): Reed-Kane Dana
Sep/Oct 2002 Pg. 338-343	Drug Therapy for Acute and Chronic Pain in the Cat Author(s): Lascelles B Duncan
Sep/Oct 2012 Pg. 431-433	Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Author(s): Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Nov/Dec 2012 Pg. 446-450	The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Author(s): Pore R David
May/Jun 2011 Pg. 259-261	Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Author(s): Jasti Bhaskara R, Saraf Poonam
May/Jun 2011 Pg. 190-192	Drug Compatibility and Stability in Dextrose vs Saline Author(s): Newton David W
Jan/Feb 2012 Pg. 62-63	The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Author(s): Bramwell Bethany L, Williams LaVonn A
Jan/Feb 2009 Pg. 14-18	Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Sep/Oct 2008 Pg. 384-390	Canine Public Servants: Caring for Drug Detection Dogs Author(s): Davidson Gigi S
Mar/Apr 2018 Pg. 92	PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 418-425	Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Mar/Apr 2017 Pg. 95-102	U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Author(s): Yoch Doug
Jul/Aug 2019 Pg. 281-287	Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations Author(s): Newton David W
Mar/Apr 2021 Pg. 100-103	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing Author(s): Riepl Mike
May/Jun 2014 Pg. 208	The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Author(s): Miller David G
Jan/Feb 2016 Pg. 71-80	A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis Author(s): Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
May/Jun 2022 Pg. 214-217	Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 268	PreScription: Pharmacy and Drug Information Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 474-481	Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 4	PreScription: New Drug Approvals 2022 and Compounding Opportunities Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 60-71	Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Author(s): Chauhan Nikita N, Patel Jayvadan K
May/Jun 2023 Pg. 180	PreScription: Shortages Continue--Compounding Pharmacies Fill the Gap…Again! Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 400-408	Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 72-79	Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021 Pg. 515-522	Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Mar/Apr 2021 Pg. 146-155	In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2016 Pg. 148-154	Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) Author(s): Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
May/Jun 2014 Pg. 180	PreScription: Déjà Vu All Over Again Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 449-450	International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Author(s): Miller David G
Nov/Dec 2020 Pg. 446-448	NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 21-27	Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Author(s): Cabaleiro Joe
Jul/Aug 2019 Pg. 271-278	Contamination Control in Compounding Areas Author(s): Mulder Kyle, Gonzales Ben A
Sep/Oct 2019 Pg. 358-364	Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Author(s): Pope George, Daleo Charles, Batson SL
Jul/Aug 2017 Pg. 301-308	Basics of Sterile Compounding: Excipients Used in Injections Author(s): Akers Michael J
Sep/Oct 2017 Pg. 388-392	Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 401-404	Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Author(s): Martin Matt
Jul/Aug 2018 Pg. 294-300	Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2 Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 220-228	Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 65-71	Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management Author(s): Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2010 Pg. 26-31	Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging Author(s): Biundo Bruce
Mar/Apr 2009 Pg. 162-165	Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers Author(s): Aloumanis Vasileios, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2009 Pg. 128-136	Compendial Activities Relating to Cold Chain Management Issues: Drug Products and Compounded Preparations Author(s): Okeke Claudia C
Nov/Dec 2011 Pg. 510-514	A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard Author(s): Walker Heather, Sridhar Vishak, Alexander Kenneth S
Sep/Oct 2011 Pg. 428-434	Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions Author(s): Roy Julie, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice
May/Jun 2001 Pg. 234-237	Preparation and Evaluation of Sustained Drug Release from Pluronic Polyol Rectal Suppositories Author(s): Anderson Derick, Amiji Mansoor M
May/Jun 2002 Pg. 230-233	Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P
May/Jun 2000 Pg. 190-193	Three Drug Stability Lives Author(s): Newton David W
Nov/Dec 1999 Pg. 439-440	Electronically Controlled Drug Delivery Author(s): Kloesel Lawson
Nov/Dec 1999 Pg. 496-500	Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Author(s): Goodwin Donald A, Fuhram L Clifton
Sep/Oct 1997 Pg. 301-305	Drug Stability and Compatibility: Special Considerations for Home Health Care Author(s): Lima Hetty A
Sep/Oct 1997 Pg. 356-358	Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions Author(s): Martinez Juan F, Trissel Lawrence A, Gilbert Doward L Jr
Sep/Oct 1998 Pg. 347-349	TPN Bulk Compounding from Bulk Drug Substances Author(s): Chamallas Stanley N
May/Jun 2004 Pg. 231-235	Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Author(s): Trissel Lawrence A, Zhang Yanping
Jan/Feb 2002 Pg. 13-15	Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective Author(s): Vail Jane
Jul/Aug 1997 Pg. 229	Animal Drug Delivery Systems Author(s): Allen Loyd V Jr
Jan/Feb 1998 Pg. 83-88	Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane Author(s): Tenjarla Srini N, Ward Earl S, Fox Janet L
Jul/Aug 2001 Pg. 314-319	Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration Author(s): Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S
Mar/Apr 2001 Pg. 101-103	Drugs Banned for Use in Food Animals: An Explanation Author(s): Davidson Gigi S
May/Jun 1999 Pg. 241-244	Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C
Jan/Feb 2006 Pg. 80	PostScription: Stopping Drug Reps at the Door Author(s): Brewer Benjamin
Jan/Feb 2007 Pg. 50-51	Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 450-451	Standard Operating Procedure: Inventory--Veterinary Drugs and Supplies Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 390-395	Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients Author(s): Davidson Gigi S
Nov/Dec 2018 Pg. 498-503	Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin Author(s): Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
May/Jun 2019 Pg. 245-249	Trends of Extemporaneous Drug Prescription in Latvia in 2017 Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta, Rogovska Irena
May/Jun 2014 Pg. 190-200	Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Author(s): McNulty John P, Muller George
Jul/Aug 2021 Pg. 282-287	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2 Author(s): Riepl Mike
Jul/Aug 2025 Pg. 319-327	Antimicrobial Effectiveness and Physicochemical Stability of Compounded Psychiatric and Neurological Drug Suspensions in SyrSpend® SF PH4 Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
Jan/Feb 2025 Pg. 22-27	Best Practices When Compounding FDA-Approved Drugs Listed in Shortage Author(s): Alliance for Pharmacy Compounding
Jan/Feb 2025 Pg. 33-36	Compounded GLP-1 Drugs and Patient Adverse Events Author(s): Alliance for Pharmacy Compounding
Mar/Apr 2025 Pg. 121	Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Author(s):
Jul/Aug 2025 Pg. 267-278	Legal Challenges to Compounding Drugs for Weight Loss Author(s): Combs Blinn E, Howard Brad
May/Jun 2015 Pg. 271	PostScription: Opportunities to Change the Pharmacy Landscape Author(s): Menighan Thomas E
Nov/Dec 2006 Pg. 462-468	Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Author(s): Huffman DC, Holmes Erin R
Nov/Dec 2003 Pg. 441-447	Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care Author(s): Fassett William E
Nov/Dec 2012 Pg. 476-478	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Jan/Feb 2009 Pg. 20-25	Compounding for Manufacturer Backorders and Discontinuations: "Oh, No! Not Again!" Author(s): McElhiney Linda F
Jul/Aug 2009 Pg. 300-310	Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting Author(s): McElhiney Linda F
Jul/Aug 2010 Pg. 322-326	Basics of Compounding: Basics of Compounding with Organic Salts Author(s): Allen Loyd V Jr
Jul/Aug 2004 Pg. 251-263	A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Author(s): Newton David W, Trissel Lawrence A
May/Jun 2005 Pg. 242-246	Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Author(s): Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
Jan/Feb 2001 Pg. 6-8	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Jul/Aug 1999 Pg. 309-310	Acidifying Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 288	Book Reviews Author(s): Reed-Kane Dana
May/Jun 2015 Pg. 223-230	Basics of Compounding: Compounding with Silicones Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 295-300	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015 Pg. 311-313	Basics of Compounding: The "Negative" List Author(s): Allen Loyd V
Jan/Feb 2015 Pg. 57-58	Basics of Compounding: The Revised "Not to Compound List" Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 101-111	Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Author(s): Timko Robert J, Crooker Philip EM
Jul/Aug 2013 Pg. 307-311	Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations Author(s): McElhiney Linda F
May/Jun 2015 Pg. 261-267	Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Author(s): Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
Mar/Apr 2016 Pg. 95-96	Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations Author(s): McCrory Gary
Sep/Oct 2015 Pg. 357-365	Novel Approaches to Topical Psoriasis Therapy Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Sep/Oct 2016 Pg. 389-396	Basics of Compounding: Clinical Pharmaceutics, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 19-21	When to Compound Medications for Veterinary Patients Author(s): Forsythe Lauren Eichstadt
Mar/Apr 2017 Pg. 127-130	Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 164-170	Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs Author(s): Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2020 Pg. 114-118	Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 156-162	Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia Author(s): Sorrieul Jérémy, Robert Julien, Chapel Fanny, Gossye Thomas, Devys Catherine
May/Jun 2020 Pg. 198-199	U.S. Food and Drug Administration Takes Aim (Again) at Animal Compounding: Draft Guidance for Industry #256 Lacks Authority, Will Increase Costs, and Put Pets at Risk Author(s): Brunner Scott
Jul/Aug 2020 Pg. 287-295	Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Author(s): McElhiney Linda F
Jul/Aug 2020 Pg. 346-351	Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review Author(s): Milibari Loay, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter
Jan/Feb 2021 Pg. 31-38	Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 369-384	Certification of Powder-containment Hoods for Nonsterile Compounding Author(s): Mulder Kyle, Dozzi Raphael
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
Mar/Apr 2018 Pg. 164-171	The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions Author(s): Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei
Jan/Feb 2019 Pg. 6-12	An Outlook on the European and Italian Rules to Guarantee Magistral Formulas Author(s): Selmin Francesca, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola
Jul/Aug 2017 Pg. 293-298	Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 446-452	Feline Transdermal Formulation Considerations Author(s): Forsythe Lauren Eichstadt
Jul/Aug 2023 Pg. 295-302	Nonsterile Basics of Compounding: Compounding with Antioxidants, Part 1: An Overview Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 92	PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap! Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 24-29	Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery Author(s): Rachmawati Putriana
Jan/Feb 2023 Pg. 30-37	Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 490-495	Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 431-439	The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet Author(s): Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Mar/Apr 2024 Pg. 111-116	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
May/Jun 2021 Pg. 222-229	Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 304-309	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 444	PreScription: The NASEM cBHT Report, Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 296-297	A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot Author(s): Brunner Scott
Jan/Feb 2022 Pg. 41-49	Sterile Basics: Compounding Sterile Preparations with Cyclodextrins Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 118-126	Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 238-244	Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website Author(s): Sluggett Janet K, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
Mar/Apr 2007 Pg. 153	Standard Operating Procedure: Discarding of Broken Glass Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 414-415	Standard Operating Procedure: Complaint and Mishap Rectification Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 213-214	What Customers Want Author(s): Roberts Jerrod L
Jan/Feb 2006 Pg. 46-49	How'd They Do That? Author(s): Roberts Jerrod L
Jan/Feb 2000 Pg. 36-38	Marketing Your Prescription Compounding Practice: Part One Author(s): Letendre William R, Jackson Richard A
Jan/Feb 2000 Pg. 40-41	Profile of a Practice Author(s): Davis Jeanie Lerche
Mar/Apr 2000 Pg. 115-117	Marketing Your Prescription Compounding Practice: Part Two Author(s): Letendre William R, Jackson Richard A
Nov/Dec 2008 Pg. 537-538	Branding: Give Your Small Business a Big Image Author(s): Storey Patricia L
Mar/Apr 2010 Pg. 124-128	Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes Author(s): Shuey Brandon, Williams LaVonn A
Jan/Feb 2014 Pg. 4	PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 86-87	PostScription: Pharmacists Advancing Toward Provider Status Author(s): Menighan Thomas E
Jan/Feb 2015 Pg. 59	Calculations Author(s): Stockton Shelly J
Jan/Feb 2015 Pg. 73-77	Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Author(s): Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
Sep/Oct 2014 Pg. 438-439	PostScription: The Future of Veterinary Compounding Author(s): Jordan Dinah G
Nov/Dec 2014 Pg. 456-460	Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date Author(s): Thomson Cassandra Marie, Savji Taslim
Jan/Feb 2015 Pg. 4	PreScription: 2014 in Review Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 43-47	Quality Control Analytical Methods: Refractive Index Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 453-463	Applying Quality of Design Concepts to Pharmacy Compounding Author(s): Timko Robert J
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Nov/Dec 2013 Pg. 520-525	Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream Author(s): Wang Xuexuan, Black Laura
Nov/Dec 2013 Pg. 465-475	Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies Author(s): Brensel Robert, Brensel Scott, Ng Amy
Mar/Apr 2014 Pg. 117-118	IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Author(s): Miller David G
Sep/Oct 2014 Pg. 415	Sulfamethoxazole and Trimethoprim Oral Solution Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 66-75	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate Author(s): Wu George, Yeung Stanley, Chen Frank
Jan/Feb 2017 Pg. 76-82	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Author(s): Wu George, Yeung Stanley, Chen Frank
Nov/Dec 2016 Pg. 477-479	The "Lists": What Do They Mean? Author(s): Voliva John
Nov/Dec 2016 Pg. 485-493	Basics of Compounding: Clinical Pharmaceutics, Part 2 Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 377-378	More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard! Author(s): Voliva John
May/Jun 2016 Pg. 250-256	Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Author(s): Trimble John, Light Bob
Jul/Aug 2016 Pg. 328-332	Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Sep/Oct 2015 Pg. 375	The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Author(s): Miller David G
Nov/Dec 2015 Pg. 505	Cefepime Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 506	Cefotaxime 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 507	Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 514-520	Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Author(s): Lobb William B, Wilkin Noel E, Holmes Erin R
Jan/Feb 2016 Pg. 41-45	Formulation and Stability of Solutions Author(s): Akers Michael J
Nov/Dec 2015 Pg. 509	Estradiol Valerate 40-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 510	Levetiracetam 100-mg/mL Injection (Concentrate) Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 92	PreScription: Compounding: A Changing Paradigm Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 155-158	Utilization of Compounded Medications in an Oral Medicine Practice Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 2016 Pg. 107-113	Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Author(s): Rabi Joseph
May/Jun 2016 Pg. 180	PreScription: Patient Access to Pharmaceuticals Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 271-274	Compounding Transdermal Medication for Feline Patients Author(s): Eichstadt Lauren R
Jul/Aug 2016 Pg. 294-296	IACP's 2016 Compounders on Capitol Hill Asks Author(s):
Mar/Apr 2019 Pg. 120-121	Patient Access Is a Patient Safety Issue Author(s): Pore David
Mar/Apr 2019 Pg. 106-111	Nimodipine Compounded Oral Suspension: A True Documented Medical Need Author(s): McElhiney Linda F
Jan/Feb 2019 Pg. 47-49	Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Author(s): Martin Matt
Sep/Oct 2018 Pg. 358-366	Current Trends and Emerging Priorities in Compounded Preparations for Children Author(s): Parrish Richard H II
Nov/Dec 2018 Pg. 516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2018 Pg. 444	PreScription: Standardized Concentrations: Pro or Con? Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 471-479	Basics of Compounding: Hot Melt Extrusion Author(s): DePasquale Seth
Nov/Dec 2017 Pg. 530-535	Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Author(s): Trimble John O, Light Bob
Jan/Feb 2018 Pg. 19-24	Pain: Systematic Review of Pharmacy Compounding of Pain Medication Author(s): Shawaqfeh Mohammad S, Harrington Catherine
Jan/Feb 2018 Pg. 26-28	The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives Author(s): Blankenship Cynthia
Mar/Apr 2018 Pg. 137-143	Basics of Compounding: Compounding Microemulsions Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 4	PreScription: Compounding Pharmacy Issues for 2017 Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 116-117	The International Academy of Compounding Pharmacists Introduces a New President Author(s): Rice Baylor
May/Jun 2017 Pg. 247-250	Warfarin Personalized Dosage: Re-compounding for a More Suitable Therapy and Better Compliance Author(s): Pellagatti Tommaso, Ternelli Marco, Frascio Davide, Bettini Ruggero
Nov/Dec 2017 Pg. 444	PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 382-383	IACP Legislative/Regulatory Update Author(s): International Academy of Compounding Pharmacists
Sep/Oct 2020 Pg. 356	Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 371-379	Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Sep/Oct 2020 Pg. 397-402	Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 320	Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 322-326	Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula Author(s): Hossain Mohammad Faisal, Levesque Dan, Frye John, Rashid Mamoon
Sep/Oct 2020 Pg. 408-412	Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested Author(s): Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson
Jul/Aug 2020 Pg. 268	PreScription: COVID-19 and Compounding Pharmacists Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 200-205	Quality Control: Photostability of Compounded Preparations Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 227	Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 242-245	Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture Author(s): Ngim Kenley, Patel Jalpa
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Jul/Aug 2019 Pg. 351	Erratum: Kiselova O, Maurina B, Sidlovska V et al. Trends of Extemporaneous Drug Prescription in Latvia in 2017. IJPC 2019; 23(3): 245-249. Author(s):
Jan/Feb 2020 Pg. 14-19	How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Author(s): Vaughn Stacey R, Radwick Allison
Jul/Aug 2019 Pg. 294-296	Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future Author(s): Brunner Scott
Sep/Oct 2019 Pg. 387-391	Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2019 Pg. 511-518	Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control Author(s): Hutson Chad, Day A J
Nov/Dec 2019 Pg. 467-471	Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2019 Pg. 472-477	Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 245	Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 94-96 View Sample	The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy Author(s): Miller David G
Jul/Aug 2012 Pg. 304-309	Selection of Color Additives: A Regulatory View Author(s): Kumar Anuj, Dureja Harish, Madan Anil K
Nov/Dec 2012 Pg. 490-496	Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 6-8	Pediatric Health Care: An Introduction Author(s): Williams LaVonn A
May/Jun 2013 Pg. 201-204	Optimizing Third-party Reimbursement for Compounded Medications Author(s): McElhiney Linda F
Sep/Oct 2013 Pg. 356	PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 358-362	Compounding Pharmacies: Before and After an Inspection Author(s): Kulkarni Darshan, Ricketts Samantha
Sep/Oct 2011 Pg. 382-384	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Jan/Feb 2013 Pg. 87	PostScription: GMPs and GCPs: A Topical Comparison Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 498-504	Case Reports: Compounding to Relieve Arthritis Pain Author(s): Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008 Pg. 524-528	Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Author(s): Trissel Lawrence A
Jul/Aug 2008 Pg. 329-333	Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Jan/Feb 2010 Pg. 78-81	Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam Author(s): Veggeland Turid, Brandl Martin
Jan/Feb 2011 Pg. 56-61	Basics of Compounding: Basics of Compounding with Potency Designated Ingredients Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 456-462	In the Hands of Your Enemy Author(s): Worthen Dennis B
Jul/Aug 2001 Pg. 254-258	Sterile Compounding with Barrier-Isolation Technology Author(s): Rahe Hank
Jul/Aug 2005 Pg. 323-326	Stability of Nebulizer Admixtures Author(s): Blondino Frank E, Baker Matthew
Mar/Apr 2005 Pg. 93-94	Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer Author(s): Reed-Kane Dana
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Sep/Oct 2003 Pg. 358-359	NDC Numbers: A New Approach Author(s): Heckman H Edward
Nov/Dec 2004 Pg. 449-450	Is Veterinary Compounding Illegal Under Federal Law? Author(s): Gibbs Jeffrey N
May/Jun 2006 Pg. 240	PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk! Author(s): Mason Dave
May/Jun 2007 Pg. 220-225	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Mar/Apr 2008 Pg. 122-127	Hormone Therapy: It's Time for a Second Opinion Author(s): Collins Joseph J, Ahlgrimm Maria
Jul/Aug 2008 Pg. 284	PreScription: First Estriol, Then What? Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 365-367	Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008 Pg. 375	PostScription: It Is Not Just What You Say…But How You Say It! Author(s): Reed-Kane Dana
May/Jun 2008 Pg. 238-241	Litigating the Legality of Compounding: The Medical Center Pharmacy Case Author(s): Gibbs Jeffrey N
May/Jun 2007 Pg. 200	Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain Author(s): Fields Shannon W
May/Jun 2022 Pg. 180	PreScription: Standing in the Gap Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 248-254	Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine Author(s): Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
Sep/Oct 2021 Pg. 356	PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800> Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 510-514	Compounding Robots for Intravenous Therapy in European Countries: A Review in 2020 Author(s): Hecq Jean-Daniel, Soumoy Laura
Jan/Feb 2022 Pg. 80-87	Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets Author(s): Azmi Nurual Hanisah Saiful, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Sep/Oct 2022 Pg. 411-418	Sterile Basics of Compounding: Contamination Control Strategies, Part 1 Author(s): Summers Amy
Sep/Oct 2022 Pg. 420	Calculations Author(s): Stockton Shelly J
Nov/Dec 2022 Pg. 474-479	Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Author(s): Maham Nicole Y
Jul/Aug 2022 Pg. 302-307	Basics: Hollow-type Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 309-315	Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program Author(s): Summers Amy
Jul/Aug 2022 Pg. 316	Calculations Author(s): Stockton Shelly J
Sep/Oct 2021 Pg. 372-377	Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Author(s): Riepl Mike
Sep/Oct 2021 Pg. 386-387	It's Time for a New Philosophy Author(s): Brunner Scott
Sep/Oct 2021 Pg. 389-395	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Jan/Feb 2022 Pg. 24-28	Editorial: Should All Pharmacists Compound? Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 30-32	Everything Old is New Again Author(s): Brunner Scott
Jan/Feb 2022 Pg. 34-38	Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 468-472	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin Author(s): Riepl Mike
Mar/Apr 2021 Pg. 131-139	Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 92	PreScription: The Past (-->2020), The Present, and The Future (2021-->) Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 156-162	Stability of Fagron's Phytobase Cream Compounded with Various Hormones Author(s): Wynn Tom, Taylor Sarah, Zander Clark
May/Jun 2021 Pg. 197-204	A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies Author(s): Hall Essence, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal
May/Jun 2021 Pg. 206-209	FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Author(s): Brunner Scott
May/Jun 2024 Pg. 188-193	Heartworm-, Flea-, and Tick-associated Diseases in Dogs: A Review of Common Parasites and Drug Classes Prophylactic Against Them Author(s): Riepl Mike
May/Jun 2024 Pg. 205-213	Prophylaxis Against Heartworm Infection and Flea or Tick Infestation in Dogs: Single Agents and Combination-Drug Products Author(s): Riepl Mike
Sep/Oct 2024 Pg. 364-372	Crushability Analysis of Immediate-Release Oral Tablets and Capsules from the 2020-22 FDA Novel Drug Approvals Author(s): Saei Kamaladdin, Schweighardt Anne, Zhao Fang
Nov/Dec 2024 Pg. 515-519	Stability Assessment of Methadone Hydrochloride Oral Solution for Dispensing in Drug Addiction Centers: A Physicochemical and Microbiological Study Author(s): Saura Mª Antonia Meroño, Sabater Pablo Selvi, Piñera Mª Pilar Sánchez, Pascual Mª Dolores Huéscar, Pérez Carmen Candel, Sanz Elena Urbieta
Mar/Apr 2023 Pg. 123-139	Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 358-360	Major Study Affirming the Relative Safety of Testosterone-replacement Therapy Author(s): Biundo Bruce
Sep/Oct 2023 Pg. 397-409	Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 522-526	Intravenous Physical Compatibility of Heparin Sodium and Furosemide Author(s): Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
Jul/Aug 2022 Pg. 293-296	Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Author(s): Harrington Amy, Williams LaVonn
May/Jun 2023 Pg. 208-210	Show Me the Science: A Perspective Author(s): Grzib Anthony
Jul/Aug 2025 Pg. 310-318	Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary Evaluation Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
Nov/Dec 2013 Pg. 480-481	HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now? Author(s): Miller David G
Nov/Dec 2013 Pg. 508-511	Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles Author(s): McPherson Timothy B, Neumann William L, Kolling William M
Nov/Dec 2013 Pg. 477-479	Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 14-19	Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Author(s): Zur Eyal
Mar/Apr 2014 Pg. 123-130	Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Author(s): Vu Nicole, Nguyen Devin, Kupiec Thomas C
Jan/Feb 2014 Pg. 46-52	Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Author(s): Hyde Tiffany D
Jan/Feb 2014 Pg. 83-86	E-Prescribing Errors Identified in a Compounding Pharmacy: A Quality-improvement Project Author(s): Reed-Kane Dana, Kittell Katrina, Adkins Jacquelyn, Flocks Sarah, Nguyen Thu
Sep/Oct 2014 Pg. 432-437	Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers Author(s): McCluskey Susan V, Sztajnkrycer Matthew D, Jenkins Donald A, Zietlow Scott P, Berns Kathleen S, Park Myung S
Sep/Oct 2014 Pg. 366-369	To Compound or Not to Compound: A Veterinary Transdermal Discussion Author(s): Eichstadt Lauren R, Davidson Gigi S
May/Jun 2014 Pg. 203-207	Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Author(s): Phan Ha, DeReese Annie, Day A J, Carvalho Maria
May/Jun 2014 Pg. 182-188	A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Author(s): Warner Meredith, Tuder Dmitry
May/Jun 2014 Pg. 228-230	Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 239	Naproxen 25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 268	PreScription: Challenging Times Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 270-276	Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety Author(s): Johnson Kain, Sully Andrew, Anthenat Bruce
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014 Pg. 293-300	Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Author(s): Kumar Anuj, Madan Anil K
Jul/Aug 2014 Pg. 302	400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill Author(s): Miller David G
Jul/Aug 2014 Pg. 305-310	Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas C
Jul/Aug 2014 Pg. 313-317	Basics of Compounding Sterile Preparations: Nomenclature and Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 325	Chloramphenicol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 327	Choline Magnesium Trisalicylate Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 332-340	Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream Author(s): Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Jul/Aug 2014 Pg. 351	PostScription: Responsibilities of a Compounding Pharmacist Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 465-469	Root Cause Analysis, Part 1: Nonsterile Compounding Author(s): Cabaleiro Joe, Jackson Kathleen
Nov/Dec 2015 Pg. 471-476	Basic Principles of Lyophilization, Part 1 Author(s): Akers Michael J
Jul/Aug 2015 Pg. 326	Benzonatate 100-mg Capsules Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 340-343	Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals Author(s): Meek Claudia, Rothardt Andrew, Evans Jason, Thurman Rosanne, Ashworth Lisa, Leff Richard
Jul/Aug 2015 Pg. 344-347	Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Author(s): Anderson Collin R, Halford Zachery, MacKay Mark
Jul/Aug 2015 Pg. 307-310	Quality Control Analytical Methods: Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units Author(s): Sidhu Raman
May/Jun 2015 Pg. 248-251	Stability of Metronidazole Suspensions Author(s): Donnelly Ronald F, Ying James
May/Jun 2015 Pg. 252-260	Protocol of Blood Serum Eye Drops Author(s): Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
Jul/Aug 2015 Pg. 266	PreScription: Potpourri of Opinions…From Many Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 268-278	Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Author(s): Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Jan/Feb 2015 Pg. 49-56	Basics of Sterile Compounding: Aseptic Processing Author(s): Akers Michael J
Jan/Feb 2015 Pg. 30-37	Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance Author(s): Grilli Anthony, Sutton Scott
Jan/Feb 2015 Pg. 38-40	Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 479-484	Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Author(s): Akers Michael J
Nov/Dec 2014 Pg. 486-488	Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 94-102	New England Compounding Center Indictment Author(s): Cabaleiro Joe
Mar/Apr 2015 Pg. 148	Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 195-203	Compounded Testosterone Troches to optimize Health and the Testosterone Controversy Author(s): Guth Michael AS
May/Jun 2015 Pg. 215-221	Quality Assurance and Quality Control, Part 2 Author(s): Akers Michael J
Jul/Aug 2016 Pg. 298-305	Basics of Compounding: Compounding Films Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 307-314	Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Author(s): Akers Michael J
Jul/Aug 2016 Pg. 316-317	Calculations Author(s): Stockton Shelly J
May/Jun 2016 Pg. 182-186	Current Perspectives on the Syringe Delivery System Author(s): Akers Michael J
May/Jun 2016 Pg. 197-201	Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Author(s): Sturn Kayla M, Collin Michael
May/Jun 2016 Pg. 233	Pain-Away II Headache Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 125-134	Basics of Compounding: Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 137-141	Formulation and Stability of Solutions Author(s): Akers Michael J
Mar/Apr 2016 Pg. 167-174	Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
Mar/Apr 2016 Pg. 99-104	Root Cause Analysis, Part 2: Sterile Compounding Author(s): Cabaleiro Joe, Jackson Kathleen
Nov/Dec 2015 Pg. 511	Memantine Hydrochloride Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 512	Mupirocin 2% Nasal Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 513	Propranolol Hydrochloride Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 86-87	PostScription: The Home Field Advantage Author(s): Cabaleiro Joe
Nov/Dec 2015 Pg. 508	Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 491-500	Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Author(s): Akers Michael J
Nov/Dec 2015 Pg. 504	Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 333-337	Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations Author(s): Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
Jul/Aug 2016 Pg. 343-346	Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump Author(s): Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
Jul/Aug 2016 Pg. 347-350	Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Author(s): Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Jul/Aug 2016 Pg. 268 View Sample	PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing? Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 359-364	Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Author(s): Deleruyelle Laura J
Nov/Dec 2016 Pg. 461-467	Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy Author(s): Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
Sep/Oct 2016 Pg. 408	Inamrinone 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 410	Naproxen 5% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 413	Sodium Phosphate Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 416-420	Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product Author(s): Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Sep/Oct 2016 Pg. 435-437	Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light Author(s): Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael
Sep/Oct 2016 Pg. 438-439	A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution Author(s): Tannous Elias, Tal Yana, Amarny Kamal
Nov/Dec 2016 Pg. 509	Flumazenil 0.1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 526-527	PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution Author(s): Rost Erika
Nov/Dec 2016 Pg. 481-484	Introduction to Quality Control in a Compounding Pharmacy Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 22-27	Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017 Pg. 31-37	Analytic Methods Used in Quality Control in a Compounding Pharmacy Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 171-175	Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
May/Jun 2017 Pg. 180	PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 242-246	Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats Author(s): Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
Mar/Apr 2017 Pg. 133-142	Accuracy Considerations in Sterile Compounding Author(s): Akers Michael J
Mar/Apr 2017 Pg. 144	Calculations Author(s): Stockton Shelly J
Mar/Apr 2017 Pg. 154-159	Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date Author(s): Gautam Pradeep, Light Bob, Purvis Troy
Nov/Dec 2019 Pg. 478-482	Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 490	Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 496-503	Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Author(s): Shakshuki Ayah, Agu Remigius U
Jan/Feb 2020 Pg. 7-12	Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets Author(s): Mulder Kyle
Sep/Oct 2019 Pg. 383-385	Threading the Needle Author(s): Brunner Scott
Sep/Oct 2019 Pg. 393-396	Basics: Excipients Used in Nonsterile Compounding, Part 2 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 434-437	Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics Author(s): Lardinois Benjamin, Baltzis Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Nov/Dec 2019 Pg. 444	PreScription: As Things Change…. Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 324-331	Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients Author(s): de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
Jan/Feb 2020 Pg. 38-43	Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 121-126	Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 128	Calculations Author(s): Stockton Shelly J
Jan/Feb 2020 Pg. 64-68	Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit Author(s): Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M
May/Jun 2020 Pg. 182-186	Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1 Author(s): Riepl Mike
Mar/Apr 2020 Pg. 163-167	Feasibility Study of Asthma Cream Author(s): Kuang Andrew
May/Jun 2020 Pg. 246-251	Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days Author(s): Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara
May/Jun 2020 Pg. 215-220	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 270-276	Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Jul/Aug 2020 Pg. 278-281	Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2 Author(s): Riepl Mike
Jul/Aug 2020 Pg. 299-303	Quality Control: Rapid Sterility Testing for Compounding Pharmacies Author(s): Taylor Andrew
Jul/Aug 2020 Pg. 305-309	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 313	Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 426-433	Efficacy of an Automated Robotic Cleaning Device for Compounding Pharmacies Author(s): Polonini Hudson, Dijkers Eli CF, Ferreira Anderson O, da Silva Sharlene L, Araújo Paulo Victor C, Koulouridas Savvas
Sep/Oct 2020 Pg. 406	Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 46	Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 73-81	Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Author(s): Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
Mar/Apr 2021 Pg. 104-108	Experimental Multidisciplinary Approach Based on Compounded Capsule's Quality Evaluation for Pharmacy Undergraduate Courses Author(s): dos Santos Matheus Skrcek Ribeiro, de Lima Amanda Muniz dos Santos, Christoff Adriana de Oliveira, Teixeira Mariana Lopes, Carneiro Jaqueline
Mar/Apr 2021 Pg. 109-113	Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic Author(s): Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
Mar/Apr 2021 Pg. 115-124	Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice Author(s): Kelley Brian
Nov/Dec 2020 Pg. 466-470	Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1 Author(s): DeRosa Angela
Nov/Dec 2020 Pg. 473-478	Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 491-500	Analysis of Extemporaneously Compounded Nasal Preparations Prescribed by Latvian Otorhinolaryngologists and General Practitioners and Comparison with German Formulations Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta
Nov/Dec 2020 Pg. 519-527	Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure Author(s): Ma Nathan, Perks William, Law Shirley, Iazzetta John, Walker Scott
Jan/Feb 2021 Pg. 4	PreScription: The NASEM cBHT Report, Part 2 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 14-17	Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2 Author(s): DeRosa Angela
Sep/Oct 2017 Pg. 384-387	Quality Control: Bar Codes and Bar Code Scanners for Unit-Dose Medications in a Healthcare Setting Author(s): Medi-Dose Inc./EPS Inc.
Sep/Oct 2017 Pg. 364-370	Child-safety Containers/Devices and Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 436-439	Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags Author(s): Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
Jul/Aug 2017 Pg. 271-274	Change Is In the Air: What You Need to Know About Pharmacy Ventilation Under United States Pharmacopeia <800> Author(s): Laniewicz Cheryl
Jul/Aug 2017 Pg. 290-291	The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871 Author(s): Rice Baylor
Jul/Aug 2017 Pg. 330-333	Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori Author(s): Mah Xian-Jun, Gupta Vikas, Loch Srey Neth, Ahlenstiel Golo, van de Poorten David
Jul/Aug 2017 Pg. 347-351	Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia Author(s): Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine
Mar/Apr 2018 Pg. 144	Calculations Author(s): Stockton Shelly J
Mar/Apr 2018 Pg. 125-126	IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing Author(s): Blankenship Cynthia
Nov/Dec 2017 Pg. 497	Tolmetin 400-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 518-529	Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland Author(s): Suvikas-Peltonen Eeva, Palmgren Joni, Häggman Verner, Celikkayalar Ercan, Manninen Raija, Airaksinen Marja
Nov/Dec 2017 Pg. 468	Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort! Author(s): Blankenship Cynthia
Jan/Feb 2018 Pg. 54	Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 60-65	Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing Author(s): Song Guiyun, Banov Daniel, Bassani August S
Jan/Feb 2018 Pg. 76-85	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018 Pg. 86-94	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Mar/Apr 2018 Pg. 172-175	Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Author(s): Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 257-263	Trace Level Analysis of Airborne Hormone Particulates Author(s): Trimble John O, Hampton Shanna
Jul/Aug 2018 Pg. 303-312	Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Author(s): Martin Matt
Jul/Aug 2018 Pg. 314	Calculations Author(s): Stockton Shelly J
Jul/Aug 2018 Pg. 270-278	Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Jan/Feb 2019 Pg. 52	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 53	Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 59	Orodispersible Film Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 92	PreScription: Compounding with Cannabidiol Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 113-119	Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia Author(s): Zur Eyal
Jan/Feb 2019 Pg. 14-21	The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Author(s): Williams LaVonn A
Jan/Feb 2019 Pg. 23-31	Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Author(s): Zur Eyal
Mar/Apr 2019 Pg. 123-130	Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 149	Dexamethasone 2 mg/g Topical Paste, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 150	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 152	Rosuvastatin 20-mg/5-mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 153	Tacrolimus 0.5 mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 208-209	Can We Fix It? Author(s): Brunner Scott
May/Jun 2007 Pg. 202-211	Levorphanol for the Treatment of Severe Chronic Pain Author(s): McNulty Jack P
Sep/Oct 2007 Pg. 404-410	Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Author(s): Allen Loyd V Jr, Okeke Claudia C
Sep/Oct 2007 Pg. 376-383	The Whales: A Pharmacist's Story Author(s): Wills William R
Nov/Dec 2007 Pg. 487-490	Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds Author(s): Trusley Craig
Nov/Dec 2007 Pg. 520-524	Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jan/Feb 2008 Pg. 8-14	Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration Author(s): Dib Jean G, Abdulmohsin Saud
Jan/Feb 2008 Pg. 65	Diclofenac Sodium 1% Soft-Patch Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 66	Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 54-60	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2008 Pg. 71	Piroxicam 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 72	Piroxicam 1% Soft-Patch Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 247-251	A Process Verification Model for Quality Assurance in a Compounding Pharmacy Author(s): Zolner William J
Mar/Apr 2008 Pg. 116-120	Establishing a Quality-Assurance Program for Hospital Compounding Author(s): McElhiney Linda F
Jul/Aug 2008 Pg. 286-292	Estriol: Women's Choice vs. A Manufacturer's Greed Author(s): Goodrum Jennifer
Mar/Apr 2008 Pg. 156-160	Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008 Pg. 170-173	Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
May/Jun 2008 Pg. 264	Meloxicam 0.3% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 180	PreScription: Pain! Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 416	Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 421	Diclofenac Sodium 75-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 83-85	Room Temperature Stability of Injectable Succinylcholine Dichloride Author(s): Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
May/Jun 2007 Pg. 181-184	Transdermal Gel in the Treatment of Postoperative Pain Author(s): Alexander Kayla, Wynn Tom
Jan/Feb 2007 Pg. 26-27	Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis Author(s): Fields Shannon W
Jan/Feb 2007 Pg. 88	PostScription: IJPC—More Than a Journal Author(s):
Jul/Aug 2007 Pg. 300	Book Review: The Rexall Story: A History of Genius and Neglect Author(s): Grajeda Betty Jo
Jul/Aug 2007 Pg. 278-281	The Politics of Hormone Replacement Therapy Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 302-305	Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Okeke Claudia C
Nov/Dec 2006 Pg. 426-427	Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard) Author(s): Benischek Rita L, Riffell Gregory S, Mauldin Todd
Jan/Feb 2007 Pg. 36-41	Information Resources and Software for the Hospital Compounding Pharmacist Author(s): McElhiney Linda F
Jul/Aug 2006 Pg. 291-292	Innovations in Compounding: Integrated Barcode System Verifies Chemical Identity, Weight Author(s): Vail Jane
Sep/Oct 2006 Pg. 351	Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches Author(s): Williams Steve D
Mar/Apr 2006 Pg. 154-155	Chemical Stability of Diclofenac Sodium Injection Author(s): Gupta Vishnu D
Nov/Dec 2006 Pg. 428-433	BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle Author(s): Benischek Rita L
Nov/Dec 2006 Pg. 434-435	Ronidazole in the Treatment of Trichomonad Infections in Cats Author(s): Davidson Gigi S
Nov/Dec 2006 Pg. 458	Indomethacin 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 459	Naltrexone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 234-236	Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
May/Jun 2006 Pg. 237-239	Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together Author(s): Gupta Vishnu D
May/Jun 2003 Pg. 170-174	Five Compounds for Treating Diabetes-Related Conditions Author(s): Meece Jerry
May/Jun 2000 Pg. 204-205	The Future of Compounding: An Industry Perspective Author(s): Capps Shelly, Winckler Susan C, Anthony Calvin J, Halperin Jerome A
Mar/Apr 2005 Pg. 167	PostScription: Experts Everywhere Author(s): Rahe Hank
May/Jun 2005 Pg. 178-182 View Sample	Update on Transdermals for Animal Patients Author(s): Davidson Gigi S
Jan/Feb 2006 Pg. 14-18 View Sample	Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery Author(s): Heim Bob
Jan/Feb 2006 Pg. 20-28	Pharmaceutical Legislation: An Historical Perspective Author(s): Worthen Dennis B
Jan/Feb 2006 Pg. 32-34	Pharmacy Compounding Urban Legends Author(s): Kastango Eric S
Sep/Oct 2004 Pg. 376-380	Basics of Compounding for Skin Discolorations Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 68	Naproxen Sodium 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 312-313	Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 25	Book Reviews: Stability and Formulation References Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 274-276	Extemporaneous Formulations in Pediatric Patients Author(s): Nahata Milap C
May/Jun 1999 Pg. 200-203	The BPS Pharmacy Specialty Certification Program Author(s): Bertin Richard J
Mar/Apr 2002 Pg. 120-122	A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Author(s): Rice Stephen P
Mar/Apr 1997 Pg. 90-92	Flavors and Flavoring Author(s): Allen Loyd V Jr
Mar/Apr 1999 Pg. 88-98	Natural Testosterone: Hormone of the Heart Author(s): Wright Jonathan V, Lenard Lane
Mar/Apr 1999 Pg. 146-147	Standard Operating Procedure for Quality Assessment of Oral and Topical Liquids Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 88-90	Complications of Diabetes Author(s): Key David M
Nov/Dec 2010 Pg. 480-483	"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care Author(s): Cox Chris
Nov/Dec 2010 Pg. 520	Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 27-31	Goliath: Case Report on a Canine Case of Epilepsy Author(s): Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Jan/Feb 2011 Pg. 41	Toxicities Associated with Topical Anesthetics Author(s): Bramwell Bethany L
Jan/Feb 2011 Pg. 44-47	Marketing Vitamins, Minerals, and Other Nutrients Author(s): Kress Robert B
Nov/Dec 2010 Pg. 512	Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 513	Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 514	Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 521	Ketoprofen 2% Oral Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 64	Diclofenac Sodium 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 66	Ibuprofen 5% Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 69	Piroxicam 1% Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 71	Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 74-77	Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Author(s): Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei
Mar/Apr 2011 Pg. 117-122	The Relevance of the Soviet Pharmaceutical Industry and Dispensing: Dependence on Traditional Compounding Author(s): Conroy Mary Schaeffer
Mar/Apr 2011 Pg. 157	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 174-175	PostScription: Commentary: Discussion on the Safety of Topical Prilocaine Author(s): Bramwell Bethany L
Mar/Apr 2010 Pg. 105-107	Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword? Author(s): Williams LaVonn A
Jul/Aug 2010 Pg. 328-331	Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2010 Pg. 341	Flurbiprofen 5% Bioadhesive Gel for Gingivitis Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 68	Ketoprofen 100-mg/5-mL Mouth Rinse Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 75	Trigger Point Gel Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 74	Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 174-175	PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort? Author(s): Allen Loyd V Jr, Burger Mark
May/Jun 2010 Pg. 180	PreScription: Healthcare Reform Is Not All That Is Happening in Washington Author(s): Menighan Thomas E
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
May/Jun 2010 Pg. 204-206	Managing Pain with Transdermal Ketoprofen Author(s): Williams KaCee D
May/Jun 2010 Pg. 241	Carprofen 2.5-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 242	Celecoxib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 218-221	Quality Control Analytical Methods: Continuous Quality Improvement Author(s): Odegard Russell D
Jul/Aug 2010 Pg. 270-274	Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Author(s): McElhiney Linda F
Jul/Aug 2010 Pg. 276-282	Recommendations for Compounding Medications for Feeding Tube Administration Author(s): Klang Mark
Jul/Aug 2010 Pg. 310-314	Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Author(s): Christiansen Joel, White Lyndell
Jul/Aug 2008 Pg. 368-371	Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Sep/Oct 2009 Pg. 438-439	Chemical Stability of Scopolamine Hydrobromide Nasal Solution Author(s): Gupta Vishnu D
Sep/Oct 2009 Pg. 440-444	Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study Author(s): Haywood Alison, Bolitho Richard, Gusti Kane, Yim Crystal, Testa Chris, Hattingh Laetitia
Sep/Oct 2009 Pg. 372-381	A Review of Stomatitis and Treatment in Cats Author(s): Ray Jody D, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E
Sep/Oct 2009 Pg. 386-389	Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Author(s): Williams LaVonn A, Fokken Dawn
Sep/Oct 2009 Pg. 404-409	An Abridged History of Aspirin Author(s): Vance Dwight A
Jan/Feb 2009 Pg. 42-49	Compounding for Cancer in Companion Animals Author(s): Mixon William, Northrup Nicole, Vail Jane
Jan/Feb 2009 Pg. 78-80	Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Author(s): Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
May/Jun 2009 Pg. 259-261	Formulation Optimization Study for an Immediate-Release Tablet Author(s): Kyriacos Soula, Dimassi Hani
May/Jun 2009 Pg. 182-190	Update on Managing Neuropathic Pain Author(s): McNulty Jack P, Muller George
May/Jun 2009 Pg. 218-219	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Nov/Dec 2008 Pg. 543	Indomethacin 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 544	Ketorolac Tromethamine 2% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 540	Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 541	Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 553-557	Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration Author(s): Shields David E, Aclan Jennifer, Szatkowski Aaron
Jan/Feb 2009 Pg. 6-12	Compounding for Pediatric Patients: Case Reports and Formulations Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Sep/Oct 2008 Pg. 446	Aceclofenac 1.5% Gel-Cream Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 460-462	Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Author(s): Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Sep/Oct 2008 Pg. 463-466	Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration Author(s): Shields David E, Aclan Jennifer, Szatkowski Aaron
Sep/Oct 2008 Pg. 414-418	Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Sep/Oct 2008 Pg. 426-430	Excipient Choices for Special Populations Author(s): Nagel-Edwards Karen M, Ko James Y
Sep/Oct 2008 Pg. 432-433	Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations Author(s): Cabaleiro Joe
Sep/Oct 2008 Pg. 452	Ketoprofen 20% Topical Solution Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 454	Piroxicam 5% and Dexpanthenol 5% Gel Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 100-110	Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists Author(s): Macklin Denise, Blackburn Paul L
Mar/Apr 2013 Pg. 130-134	Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program Author(s): Griffiths Tricia, Connors Anne
Mar/Apr 2013 Pg. 168-174	Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Author(s): Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
May/Jun 2013 Pg. 193-199	Decontamination Technology: The Missing Element Author(s): Rahe Hank
Sep/Oct 2013 Pg. 364-368	Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms Author(s): McElhiney Linda F
Sep/Oct 2013 Pg. 419	Indomethacin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 436-438	Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration Author(s): Ramaley Corrine C, Li Feng, Du Chengan
Nov/Dec 2013 Pg. 459-463	Considerations for Pharmacists Working in Major Disaster Areas Author(s): Kawataba Yoshinori
May/Jun 2013 Pg. 262-263	PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial Author(s): Williams LaVonn A
Jul/Aug 2013 Pg. 270-280	Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Author(s): Logomasini Mark A, Stout Richard R, Ron Marcinkoski
May/Jun 2013 Pg. 210-219	Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 228	Buffered Aspirin Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 229	Calcium Acetate 667-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 230	Estradiol 0.5-mg, 1-mg, or 2-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 231	Ethambutol 400-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 232	Isoniazid 300-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 233	Labetalol 50-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 234	Mercaptopurine 75-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 235	Naltrexone Hydrochloride 50-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 236	Prednisone 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 237	Reserpine 0.5-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 10-22	Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Author(s): Zur Eyal
Jan/Feb 2013 Pg. 67	Ibuprofen 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Nov/Dec 2012 Pg. 471-474	Beyond-use Date: Establishment and Maintenance Author(s): Osteen Richard
Jul/Aug 2012 Pg. 337	Ketorolac Tromethamine 15-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 270-274	A Concise Discussion of Headache Types, Part 3: Migraine Author(s): Williams LaVonn A, Allen Loyd V Jr
Sep/Oct 2012 Pg. 369-375	Medical Therapy for Acquired Urinary Incontinence in Dogs Author(s): Hill Katie, Jordan Dinah, Ray Jody, Mays Andrew A, Griffin Katie
Sep/Oct 2012 Pg. 382-384	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Sep/Oct 2012 Pg. 386-393	Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Author(s): Zur Eyal
Mar/Apr 2012 Pg. 98-102	Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes Author(s): Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, do Carmo Garcez Maria
Mar/Apr 2012 Pg. 125-132	A Concise Discussion of Headache Types, Part 1 Author(s): Williams LaVonn A
May/Jun 2012 Pg. 180	PreScription: Working in Handcuffs Author(s): Menighan Thomas E
May/Jun 2012 Pg. 253-256	Compounding and Dispensing Errors Before and After Implementing Barcode Technology in a Nuclear Pharmacy Author(s): Galbraith Wendy, Shadid Jill
Nov/Dec 2011 Pg. 521-525	Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant Author(s): Jha Antesh Kr, Chetia D
Jan/Feb 2012 Pg. 82-85	Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration Author(s): Zhang Yang, Scarlett Cameron, Hutson Paul
Jan/Feb 2012 Pg. 54-56	Institute for Safe Medication Practices Lifetime Achievement Award 2011 Author(s): Trissel Lawrence A
Sep/Oct 2011 Pg. 356	PreScription: Third-party Inequities and Discrimination Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 356	PreScription: American Pharmacists Month: A Time for Taking Responsibility Author(s): Menighan Thomas E
Sep/Oct 2011 Pg. 438-439	PostScription: Compounders Go Above and Beyond in the Name of Safety Author(s): Gates Ernest P Jr
Nov/Dec 2011 Pg. 444	PreScription: Compounding: Keeping Elephants Our of Our Mouseholes Author(s): Menighan Thomas E
Nov/Dec 2011 Pg. 471-472 View Sample	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Nov/Dec 2011 Pg. 474-479 View Sample	The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire Author(s): Miller David G
May/Jun 2011 Pg. 234-238	Basics of Compounding: Basics of Compounding with Complex Organic Molecules Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 242	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 243	Diclofenac Sodium 1% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 244	Ibuprofen 5% Topical Cream Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 344-349	Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate Author(s): Hergert Lisandro Y, Sperandeo Norma R, Allemandi Daniel A, Mazzieri Maria R
Jul/Aug 2011 Pg. 268	PreScription: Two Lessons in 17-Hydroxyprogesterone Author(s): Menighan Thomas E
Jul/Aug 2011 Pg. 290-300	Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review Author(s): Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Nov/Dec 2023 Pg. 461-466	Considerations in Qualifying Critical Suppliers Author(s): Summers Amy
Jul/Aug 2023 Pg. 305-313	Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 314	Calculations Author(s): Stockton Shelly J
Mar/Apr 2023 Pg. 108-112	Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Author(s): Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
Mar/Apr 2023 Pg. 169-174	Comparison of Three Reconstitution Devices: A Simulated Time and Use Study Author(s): Penoyer Daleen, Giuliano Karen, Middleton Aurea
Jan/Feb 2023 Pg. 72-77	Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base Author(s): Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Nov/Dec 2023 Pg. 494-502	Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications Author(s): Dharmian Jose Prakash, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
Nov/Dec 2023 Pg. 512-521	Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics Author(s): Rofiq Hanifah Mohd, Phang Hiu Ching, Janakiraman Ashok Kumar, Chew Yik-Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 118-119	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Mar/Apr 2024 Pg. 130	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 131	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 134	Diclofenac Sodium 1% Soft-patch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 94-98	The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report Author(s): McKettrick Greg, Yoch Doug
Jul/Aug 2021 Pg. 311-317	Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 336-343	Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Author(s): Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Jul/Aug 2021 Pg. 344-351	Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
May/Jun 2021 Pg. 241-245	In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester Author(s): McKinney Rachael D, Dunbar Jacob R
Jul/Aug 2021 Pg. 288-295	Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta
Nov/Dec 2021 Pg. 491-496	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 498	Calculations Author(s): Stockton Shelly J
Nov/Dec 2021 Pg. 505	Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 298-302	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Sep/Oct 2021 Pg. 403-408	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 422-426	Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application Author(s): Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
Jul/Aug 2022 Pg. 325-326	Indomethacin 1% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 356	PreScription: A New Dosage Form Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 283-291	Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules Author(s): de Oliveira Ferreira Anderson, Polonini Hudson
Sep/Oct 2022 Pg. 370-377	Recent Formulation Advances and Preparation of Orally Disintegrating Tablets Author(s): Ejeta Fikadu
Sep/Oct 2022 Pg. 396-398	The FDA is in a Hole. It Should Stop Digging. Author(s): Brunner Scott
Sep/Oct 2022 Pg. 427	Cysteamine Hydrochloride 100 mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 430	Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 55	Diclofenac Sodium 1%-15% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 219-228	Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 155-162	Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate Author(s): Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Mar/Apr 2022 Pg. 163-174	Molding as Innovative Technology for Personalized Tablet Production Author(s): Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Nov/Dec 2018 Pg. 475-478	Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 Author(s): Martin Matt
Jan/Feb 2007 Pg. 59-65	Pharmacogenomics: The End of Trial-and-Error Medicine? Author(s): Vail Jane
Jan/Feb 2007 Pg. 5-8	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald

Related Articles